アステラス薬：XOSPATA (gilteritinib) Approved by U.S. FDA for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) with a FLT3 Mutation - 有報キャッチャー

アステラス薬（4503）　XOSPATA (gilteritinib) Approved by U.S. FDA for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) with a FLT3 Mutation 2018/11/29

/-

読み込み中…